Andere Sprachen Azitra, Inc.

Aktien

A3D8GZ

US05479L1044

AZTR

Verzögert Nyse Andere Börsenplätze 15:34:56 28.05.2024			% 5 Tage	% 1. Jan.
0.1912 ^USD	+0.53%		-4.40%	-79.22%

10.05.	Azitra, Inc. gibt positive präklinische Daten von ATR-12 und klinisches Design beim Netherton-Syndrom bekannt, die auf der ASGCT-Jahrestagung vorgestellt wurden	CI
09.05.	Azitra, Inc. meldet Ergebnis für das erste Quartal zum 31. März 2024	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Azitra Announces Positive Preclinical Data from ATR-04 Presented at the Society of Investigative Dermatology Annual Meeting	20.05.
Azitra, Inc. Announces Positive Preclinical Data from ATR-04 Presented at the Society of Investigative Dermatology Annual Meeting	17.05.
Azitra, Inc. Announces Positive Preclinical Data of ATR-12 and Clinical Design in Netherton Syndrome Presented at the ASGCT Annual Meeting	13.05.
Azitra, Inc. Announces Positive Preclinical Data of ATR-12 and Clinical Design in Netherton Syndrome Presented at the ASGCT Annual Meeting	10.05.
Azitra, Inc. Announces Positive Preclinical Data of ATR-12 and Clinical Design in Netherton Syndrome Presented at the ASGCT Annual Meeting	10.05.
Azitra, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	09.05.
Azitra, Inc. Announces Q1 2024 Financial Results and Provides Business Updates	09.05.
Azitra, Inc. Announces New Preclinical Data to be Presented at the American Society of Gene and Cell Therapy Meeting	22.04.
Azitra, Inc. Announces New Preclinical Data to be Presented at the American Society of Gene and Cell Therapy Meeting	22.04.
Azitra, Inc. to Present New Data at Three Upcoming Scientific Conferences in May 2024	18.04.
Azitra, Inc. Announces Full Year 2023 Financial Results and Provides Business Updates	15.03.
Azitra, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	15.03.
Azitra Closes $5 Million Public Offering	16.02.
Azitra, Inc. Announces Closing of Public Offering	16.02.
Top Midday Decliners	14.02.
Azitra Prices Stock Offering at $0.30 a Share	14.02.
Azitra, Inc. Announces Pricing of Public Offering	14.02.
Azitra Launches Common Stock Offering; Shares Drop	19.01.
Azitra, Inc. Strengthens Intellectual Property Portfolio with Newly Granted Patent in the US	16.01.
Azitra, Inc. to Present at Biotech Showcase 2024 and the Dermatology Summit 2024, Alongside the J.P. Morgan Annual Healthcare Conference	03.01.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Azitra, Inc.

Aktien

A3D8GZ

US05479L1044

AZTR

Andere Sprachen

Filter